LeptoVax 4/C

This page contains information on LeptoVax 4/C for veterinary use.
The information provided typically includes the following:
  • LeptoVax 4/C Indications
  • Warnings and cautions for LeptoVax 4/C
  • Direction and dosage information for LeptoVax 4/C

LeptoVax 4/C

This treatment applies to the following species:
Manufacturer: Boehringer Ingelheim

Canine Coronavirus Vaccine

Killed Virus

Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract

For Use in Dogs Only

For Veterinary Use Only

For subcutaneous vaccination of healthy dogs 6 weeks of age or older as an aid in the prevention of disease caused by canine coronavirus, Leptospira canicola, Leptospira grippotyphosa, Leptospira icterohaemorrhagiae and Leptospira pomona.

Dosage and Route of Administration:

Dogs: Inject 1 mL subcutaneously in dogs six weeks or older. Administer a second dose in two to four weeks. Annual revaccination with one dose is recommended.

The PEEL-OFF LABEL I.D. SYSTEM provides a simple and effective method of recording pertinent information on the vaccines administered to animals in a veterinary practice.

For vaccines requiring reconstitution, remove label from both vials and affix both labels to the animal’s medical chart.

Using the System:

1.

Grasp the vial label at the corner marked with an indicator arrow, between your thumb and forefinger (figure 1).

2.

Pull steadily at a slight angle until the label is separated from the vial (figure 2).

3.

Place the label on the animal’s medical chart. Press down on the label to ensure adhesion.

LeptoVax 4/C Caution

DO NOT USE AS DILUENT FOR LIVE VACCINES. Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. SHAKE WELL. In case of anaphylactoid reaction, administer epinephrine. Burn container and all unused contents.

Gentamicin and thimerosal added as preservatives.

LeptoVax 4/C Caution

In the absence of a veterinarian-client-patient relationship, Federal law prohibits the relabeling, repackaging, resale, or redistribution of the individual contents of this package.

LeptoVax® is a registered trademark of Boehringer Ingelheim Vetmedica, Inc.

© 2011 Boehringer Ingelheim Vetmedica, Inc. All Rights Reserved.

Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506 U.S.A.

U.S. Veterinary License No. 124

25 Doses

25 x 1 mL Vials of Vaccine

10411

D6485C

NAC No.: 10282471

BOEHRINGER INGELHEIM VETMEDICA, INC.
2621 NORTH BELT HIGHWAY, ST. JOSEPH, MO, 64506-2002
Telephone:   800-325-9167
Fax:   816-236-2717
Website:   www.bevaccinesmart.com
    www.bi-vetmedica.com
    www.productionvalues.us
    www.prrsresearch.com
    www.thinkmetacam.com
    www.vetera-vaccines.com
    www.vetmedin-us.com
    www.yourdogsheart.com
Email:   info@productionvalues.us
Every effort has been made to ensure the accuracy of the LeptoVax 4/C information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-07-28

(web4)